Section Arrow
Quote
CDNA.NASDAQ
- CareDx
Quotes are at least 15-min delayed:2024/05/20 17:05 EDT
Last
 15.63
+0.13 (+0.84%)
Day High 
15.81 
Prev. Close
15.5 
1-M High
16.15 
Volume 
581.09K 
Bid
15.64
Ask
17
Day Low
15.0646 
Open
15.08 
1-M Low
7.42 
Market Cap 
807.30M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 13.2 
20-SMA 10.78 
50-SMA 10.14 
52-W High 16.15 
52-W Low 4.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.42/-1.37
Enterprise Value
835.58M
Balance Sheet
Book Value Per Share
4.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
280.32M
Operating Revenue Per Share
5.71
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
EXASExact Sciences Corp51+0.62+1.23%-- 
DMTKDermTech0.3601-0.1394-27.91%-- 
GHGuardant Health24.77-0.59-2.33%-- 
ME23andMe Holding Co0.5466-0.0402-6.85%-- 
OPKOPKO Health1.32--0.000%-- 
Quotes are at least 15-min delayed：2024/05/20 17:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.